XML 53 R34.htm IDEA: XBRL DOCUMENT v3.25.4

Net Loss Per Share (Tables)

12 Months Ended

Dec. 31, 2025

Earnings Per Share [Abstract]

Schedule of computation of basic and diluted net (loss)/income per share

The following table sets forth the computation of basic and diluted net loss per share for the years ended December 31, 2025 and 2024 (in thousands, except number of shares and per share amounts):

			Year Ended December 31,
Numerator:			2025						2024
Net loss			$	(66,458)					$	(61,183)
Net loss attributable to noncontrolling interest			30						109
Net loss attributable to Barinthus Biotherapeutics plc shareholders			$	(66,428)					$	(61,074)
Denominator:
Weighted-average ordinary shares outstanding, basic			40,527,218						39,348,240
Weighted-average ordinary shares outstanding, diluted			40,527,218						39,348,240
Net loss per share attributable to ordinary shareholders, basic			$	(1.64)					$	(1.55)
Net loss per share attributable to ordinary shareholders, diluted			$	(1.64)					$	(1.55)

X

- References

No definition available.

+ Details

Name:	us-gaap_EarningsPerShareAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration